Diagnostic device company OOVA, Inc., a Mount Sinai Health System spinout, is piloting a fertility monitoring tool through a partnership with Thorne Research
The ads will also be aired during other prominent shows in the New York market over the next several months.
Seven Other Departments Ranked Among Top 10 Nationally
As part of nationwide efforts to improve emergency medical care, researchers at the Mount Sinai Health System, in collaboration with UC San Diego Health, have released a national framework report titled “Promoting Innovations in Emergency Medical Services” that identifies regulatory, financial, and technological obstacles to improving local and state EMS systems.
New program will look at the role of the Follicle Stimulating Hormone in obesity and osteoporosis
The Department of Rehabilitation and Human Performance at the Mount Sinai Health System has become the official medical services provider on the East Coast for U.S. Red Bull athletes and Red Bull’s athlete performance programs.
This study is the first to report a possible mechanism for the enhancement of Zika virus progression during pregnancy in an animal model.
Current tools used to predict prostate cancer progression are generally subjective in nature, leading to differing interpretations among clinicians
Second annual live surgery training to educate health care professionals about gender affirmation procedures
Physicians announce new research on sleep and heart disease, and expansion of heart services in New York City
A multi-institutional research team will develop and evaluate a pregnancy-specified Artificial Pancreas
In honor of American Heart Month in February, the Mount Sinai Health System will host several “Go Red" Community Heart Health Fairs throughout its system.
The Icahn School of Medicine at Mount Sinai has entered into two exclusive licenses to develop the drug pentosan polysulfate sodium for the treatment of mucopolysaccharidosis (MPS).
Herpes viral infections use the ancient genetic material found in the human genome to proliferate, mimicking the same process tumors have been found to manipulate, Mount Sinai researchers have shown for the first time. These observations provide further insight about how herpes viruses can manipulate the immune system in ways that may drive neurodegenerative diseases like Alzheimer’s, according to the study, published in Nature Communications in January.
Third-Round Investment by Mount Sinai Ventures in Online Meal Delivery Service Start-Up Heralds the Growing Benefits of “Food as Medicine”
Mount Sinai Experts Weigh In On Diagnosis, Prevention, Risk & Treatment Options
First program on East Coast to receive highest level of recognition
The Department of Urology at the Mount Sinai Health System has partnered with the nonprofit organization Man Cave Health to launch a first-of-its-kind sports-themed resource center for men that will provide educational resources on prostate health.
Seaver Autism Center study results contribute to understanding of patterns of cognitive functioning in adults with autism and highlight the importance of a broader approach when studying cognition
Until now, studies on the APOL1 gene have primarily focused on African and African American populations
Screening method shows promise as a key to faster therapeutic innovation
An international consortium of researchers identify genetic underpinnings associated with PCOS to understand and better diagnose it
Appointments Strengthen Institute’s Efforts to Improve Health of People and Communities Locally and Abroad
A further step toward a cure for diabetes
New appointments will enhance pediatric care, research, and education
Mount Sinai Health System today opened a new, full-service center called Mount Sinai Express Care that offers immediate care for minor injuries and illnesses.
In a study published today in Gastroenterology, a team of researchers from the Icahn School of Medicine at Mount Sinai and elsewhere finds that there is no association between post-inflammatory polyps (PIPs), also known as pseudopolyps, and advanced colorectal neoplasia (CRN) in patients with inflammatory bowel disease (IBD).
Chan Zuckerberg Initiative Funding Brings Together Interdisciplinary Experts to Accelerate Understanding
Move to Provide Broader Access to Advanced Care and Innovative Clinical Trials to Better Serve South Shore and Long Island
For the 10th year in a row, Mount Sinai Health System’s Mitral Valve Repair Center received honors at the Annual eHealthcare Leadership Awards, announced at the 2018 Healthcare Internet Conference in Scottsdale, Arizona
Mount Sinai study discovers that imagining threats can weaken reactions to them by suppressing perceptual and learning neural mechanisms
The Graduate School of Biomedical Sciences at the Icahn School of Medicine at Mount Sinai is pleased to announce a new Master of Biomedical Data Science (MSBDS) degree. Applications are open now through June 2019 for enrollment in the fall of 2019.
In a study designed to evaluate second-hand marijuana smoke exposure among children—a topic that scientists have not yet widely addressed—researchers at the Icahn School of Medicine at Mount Sinai found that nearly half of children whose parents smoked marijuana showed evidence of second-hand marijuana smoke exposure. The study appears in the December issue of Pediatrics.
Partnership Will Transform Health Care Delivery at Taikang’s Xianlin Drum Tower Hospital in Nanjing, Jiangsu Province, China
In a world where Big Data reigns, fast, open, and free analysis is key
RenalytixAI PLC, a Mount Sinai exclusive licensee and development collaborator, had completed a public listing that valued the company at $85 million on the London Stock Exchange’s Alternative Investment Market.
Appointment of new CMO to Mount Sinai Health System
New Diagnostic Technology Will Provide Information to Both Patients and Clinicians
Study shows deep learning models must be carefully tested across multiple environments before being put into clinical practice.
Study could transform care for organ transplant recipients
Vascular specialists at the Icahn School of Medicine at Mount Sinai are the first in the United States to use the Eluvia™, a drug-eluting vascular stent system for clinical treatment of peripheral artery disease (PAD), a circulatory condition that causes a narrowing of the blood vessels and a reduction of blood flow to the limbs.
Mount Sinai Experts Weigh In on Self-Management, Treatment Options, Reversing the Disease and the Newest Advances in Diabetes Research
People with Alzheimer’s disease who were treated with diabetes drugs showed considerably fewer markers of the disease—including abnormal microvasculature and disregulated gene expressions—in their brains compared to Alzheimer’s patients without treatment for diabetes, Mount Sinai researchers report.
Researchers from the Icahn School of Medicine at Mount Sinai found that patients with Major Depressive Disorder (MDD) exhibited a significant reduction of depressive symptoms after being treated with ezogabine, an FDA approved drug used to treat seizures.
Launches Newly Renamed Institute for Data Science and Genomic Technology
Using evidence found in teeth from two Neanderthals from southeastern France, researchers from the Department of Environmental Medicine and Public Health at the Icahn School of Medicine at Mount Sinai report the earliest evidence of lead exposure in an extinct human-like species from 250,000 years ago.
The Brain & Behavior Research Foundation, the world’s largest private funder of mental health research grants, honored two Mount Sinai researchers with its 2018 Outstanding Achievement Prizes at its International Awards Dinner on Friday, October 26, in New York City. The evening celebrated the power of neuroscience, psychiatric research, and humanitarian efforts to change the lives of people who are living with mental illness.
New method developed by Mount Sinai team allows systematic study of effects of a wide range of drugs on the developing fetus
Researchers from the Icahn School of Medicine at Mount Sinai have found clear disparities in the way males and females—both those with schizophrenia and those who are healthy—discern the mental states of others.
Icahn School of Medicine is designated a certified mitochondrial care center as part of the newly formed Mitochondrial Care Network
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right